Precipio Announces Q2-2019 Corporate Update Call for Shareholders
August 13 2019 - 9:15AM
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO)
will be hosting its Second quarter 2019 corporate update call
on Wednesday, August 21st at 5:00 PM ET, following its recent
filing of its Form 10-Q on August 9th, 2019 and the release of its
financial results for the second quarter ending June 30, 2019.
The conference call may be accessed by calling 844-695-5519
(international callers dial 1-412-902-6760). All callers should ask
for the Precipio Inc. conference call. Participants may also
pre-register for the conference call at
http://dpregister.com/10134377 and will receive a
calendar invite and a direct dial-in number, bypassing the
operator.
Listeners interested in submitting questions in advance should
email their questions to investors@precipiodx.com and management
will do its best to address those questions during the call.
A replay of the call will be available approximately 24 hours
after the call and may be accessed via the Investors page on
Precipio’s website, http://www.precipiodx.com/investors.html.
About Precipio
Precipio has built a platform designed to eradicate the problem
of misdiagnosis by harnessing the intellect, expertise and
technology developed within academic institutions and delivering
quality diagnostic information to physicians and their patients
worldwide. Through its collaborations with world-class academic
institutions specializing in cancer research, diagnostics and
treatment such as the Yale School of Medicine and Harvard’s
Dana-Farber Cancer Institute, Precipio offers a new standard of
diagnostic accuracy enabling the highest level of patient care. For
more information, please visit www.precipiodx.com.
Forward-Looking Statements
Certain statements in this press release
constitute “forward-looking statements,” within the meaning of
federal securities laws, including statements related to ICP
technology, including financial projections related thereto and
potential market opportunity, plans and prospects and other
statements containing the words “anticipate,” “intend,” “may,”
“plan,” “predict,” “will,” “would,” “could,” “should,” and similar
expressions, constitute forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995.
The Company's actual results could differ materially from those
anticipated in these forward-looking statements as a result of
various factors. Factors that could cause future results to
materially differ from the recent results or those projected in
forward-looking statements include the known risks, uncertainties
and other factors described in the Company’s definitive proxy
statement filed on April 29, 2019 , the Company’s Quarterly Report
on Form 10-Q for the quarter ended June 30, 2019 and on the Annual
Report on Form 10-K for the year ended December 31, 2018 as well as
the Company’s prior filings and from time to time in the Company’s
subsequent filings with the Securities and Exchange Commission. Any
change in such factors, risks and uncertainties may cause the
actual results, events and performance to differ materially from
those referred to in such statements. All information in this press
release is as of the date of the release and the Company does not
undertake any duty to update this information, including any
forward-looking statements, unless required by law
Inquiries:
investors@precipiodx.com
+1-203-787-7888
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Precipio (NASDAQ:PRPO)
Historical Stock Chart
From Apr 2023 to Apr 2024